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n Abstract: To determine which tumor-related factors might predispose the patient to loco-regional recurrence or death
and the impact of these factors on the different types of events. We retrospectively analyzed the data of 1991 women
between January 1998 and March 2010 for a first primary nonmetastatic breast cancer and treated with surgery and neo-
adjuvant ⁄adjuvant therapy. The overall survival distribution was estimated using the Kaplan–Meier method. The prognostic
impact of several factors on cumulative overall and loco-regional recurrence free survival was evaluated by univariate (log-
rank test) and multivariate analysis (Cox regression). At log-rank test, pT, nodal status, histotype, grading, lymphangioinva-
sive growth, tumor diameter, estrogen receptors (ER) status, progesterone receptors (PR) status, expression of Ki67, and
expression of Her2 ⁄neu had a prognostic value on loco-regional recurrence or overall survival. In the multivariate analysis
grading remained the only independent predictor of loco-regional recurrences. With regard to overall survival, the Cox
model selected grading along with nodal status and PR status. Loco-regional recurrences after breast cancer surgery are
not frequent events. They are markers of tumor aggressiveness and predictor of an increased likelihood of cancer-related
death. However, loco-regional recurrence and systemic tumor progression are partially independent events, since some
prognostic factors differ. n
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Today, in minimally invasive surgery era, outcomeof breast cancer patients after breast-conserving
surgery seems better than outcome after mastectomy:
actually, this effect is due to many early-stage diseases
treated by conservative excision (1–4). However, while
surgical procedure cannot be considered a prognostic
factor for these patients, there is the need to detect
reliable predictors of loco-regional recurrence, a mar-
ker of tumor aggressiveness linked to an increased risk
of distant metastases and death (5–11). In fact, by
identification of stronger pathologic and molecular
predictors of loco-regional recurrence and more effec-
tive treatment strategies, the risk of local failure after
breast surgery could decrease.
In this study, we analyzed data on 1991 women
underwent surgery for breast cancer in order to
determine which tumor-related factors might predispose
the patient to loco-regional recurrence or death and to
determine the impact of these factors on the different
types of events.
PATIENTS AND METHODS
Study Population
We retrospectively analyzed the data of 1991
women hospitalized at the University of Insubria Hos-
pital in Varese between 1 January 1998 and 30 March
2010 for a first primary nonmetastatic breast cancer
and treated with surgery and neo-adjuvant ⁄adjuvant
therapy. Women were usually followed up by physical
examination every 6 months and mammography with
breast ultrasound (US) annually; in symptomatic cases
or when clinically indicated, bone scan, chest x-ray,
liver US or computed tomography scan were carried
out.
Definitions of End Points
Loco-regional recurrence was defined as recurrence
in the original tumor bed or in the ipsilateral axillary,
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internal mammary or supraclavicular or infraclavicular
nodes with the same histopathologic features of the
primary tumor. Regarding to end point of death, we
considered only deaths for breast cancer.
Statistical Methods
The overall survival distribution was estimated
using the Kaplan–Meier method (12). New ipsilateral
breast tumor, contralateral breast tumor, distant
metastases onset and other nonbreast primary tumor
were considered as censoring events for loco-regional
recurrence free survival and death for other causes as
censoring event for overall survival. In the absence of
any of these events, the observation time was censored
at the last follow-up visit. The prognostic impact of
several factors on cumulative overall and loco-regional
recurrence free survival was evaluated by log-rank test
(13). Continuous variables were categorized according
to the median value. In order to consider only tumor-
related factor, we excluded from analysis any patient-
and treatment-related factors. Variables reaching a
p value <0.1 in the univariate analysis were regressed
on the cause-specific hazard, using multivariate Cox
proportional hazards model (14). The stepwise (back-
ward elimination) procedure was used. The effect of
each factor was expressed as hazard ratio (HR) with
95% confidence intervals (CIs). The proportional
hazard assumption was controlled using goodness of
fit tests. The statistical analysis was performed with
SPSS software for Windows. All reported p-values
were two-sided.
RESULTS
Median age was 61.1 years (range 24–96). Median
follow-up was 53 months (range 1–148), with 44.7%
of patients having a follow-up >5 years. Table 1
shows the tumor-related factors of the cohort consid-
ered for analysis.
We observed 144 loco-regional recurrences and 55
cancer-related deaths as events, corresponding to a
5-year cumulative overall survival of 96.4% (Fig. 1)
and a 5-year cumulative loco-regional recurrence free
survival of 91.5% (Fig. 2).
Table 2 shows the univariate analysis of prognostic
factors. pT, nodal status, grading, lymphangioinvasive
growth, tumor diameter, ER status, PR status, and
expression of Her2 ⁄neu had a prognostic value on
loco-regional recurrence. At the univariate analysis of
overall survival the histotype and the expression of
Ki67 also were associated with outcome (but not the
lymphangioinvasive growth).
In the multivariate analysis, reported in Table 3,
grading remained the only independent predictor of
loco-regional recurrences. With regard to overall sur-
vival, the Cox model selected grading along with
Table 1. Study Population Tumor-Related Fac-
tors Considered for Analysis
Variable Category No. (%)
Tumor diameter* <15 mm 784 (50.1)
‡15 mm 782 (49.9)
pT* pT0–1 1356 (68.8)
pT2 524 (26.6)
pT3 36 (1.8)
pT4 55 (2.8)
pN* pN0 1385 (72.7)
pN1 354 (18.6)
pN2 119 (6.2)
pN3 48 (2.5)
Histotype* Ductal 1478 (74.4)
Lobular 214 (10.8)
Other 294 (14.8)
Estrogen receptors* Negative 275 (15.0)
Positive 1556 (85)
Progesterone receptors* Negative 427 (23.1)
Positive 1419 (76.9)
Grading* G1–2 1379 (75.4)
G3 449 (24.6)
Her2 ⁄ neu* Overexpressed 569 (36.5)
Not expressed 989 (63.5)
Ki67* <20% 777 (49.9)
‡20% 779 (50.1)
p53* Overexpressed 857 (56.6)
Not expressed 658 (43.4)
Lymphoangioinvasive growth* Absent 422 (76.2)
Present 132 (23.8)
*Data not available for all patients.
Figure 1. Cumulative overall survival for study patients.
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nodal status and PR status as statistically significant
independent prognostic factors.
DISCUSSION
The revolution of breast cancer treatment during
the past decades has led to the progressive reduction
of the surgical extent (1–4,15,16). Consequently, the
quality of life has improved and women are now more
motivated to follow screening programs for early diag-
nosis of the disease. The most relevant problem in
breast-conserving surgery remains the loco-regional
recurrence, which can nullify the aim of conservation
for subsequent mastectomy.
In the present series, we verify the predictive factors
of loco-regional recurrence and survival in a large ser-
ies of patients treated by surgery. In this all-stages
patients sample we observed a low incidence of loco-
regional recurrences (8.5% at 5 years). This important
result highlights the clear improvement of the surgical
approach in local control obtained in the last few
years. With this regard, the distinction between true
loco-regional recurrences and new primary tumors
arising in the ipsilateral breast is important, since they
may have different biologic behavior and prognosis
and a true recurrence might denote a persistent, radio-
resistant, drug-insensitive and potentially more dan-
gerous disease (17,18).
Even if local failure has been linked to an increased
risk of distant metastases and death (5–11), in our
study the 5-year cumulative rate of loco-regional
recurrences was significantly higher than 5-year rate
of cancer-related death (8.5% versus 3.6%). There-
Figure 2. Cumulative loco-regional recurrence free survival for
study patients.
Table 2. Univariate Analysis of
Predictive Factors for Events
Variable Category
5-year loco-regional
recurrence free
survival (%) p-value
5-year overall
survival
(%) p-value
Tumor diameter <15 mm 96.0 <0.001 98.5 0.004
‡15 mm 89.0 95.6
pT pT0–1 95.7 <0.001 99.0 <0.001
pT2 86.3 93.9
pT3 75.3 85.4
pT4 74.9 86.9
pN pN0 94.5 <0.001 98.5 <0.001
pN1 92.0 95.8
pN2 77.8 90.6
pN3 52.3 71.9
Histotype Ductal 91.1 0.168 95.6 0.018
Lobular 93.4 98.4
Other 92.5 98.7
Estrogen
receptors
Negative 84.9 0.021 92.6 0.002
Positive 92.4 97.2
Progesterone
receptors
Negative 85.6 0.002 92.2 <0.001
Positive 93.2 98.0
Grading G1–2 94.2 <0.001 97.9 <0.001
G3 82.4 91.1
Her2 ⁄ neu Overexpressed 87.7 0.034 94.7 0.052
Not expressed 93.9 97.4
Ki67 <20% 93.9 0.057 98.0 0.016
‡20% 90.1 95.1
p53 Overexpressed 91.7 0.951 96.3 0.760
Not expressed 93.3 97.0
Lymphoangioinvasive growth Absent 92.8 0.016 94.0 0.07
Present 75.3 91.2
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fore, loco-regional recurrence should not be consid-
ered as a failure of surgical approach (conservative or
not) or responsible for systemic progression by itself:
in fact, previous trials have shown that patients with a
high incidence of local recurrences have the same sur-
vival rate as patients with a low local recurrence rate
(1,2). Hence, loco-regional recurrence can be evalu-
ated as a marker of tumor aggressiveness and a pre-
dictive factor for distant metastases and death
(6,11,19–21), but as a condition still susceptible of
cure.
By identification of loco-regional recurrence tumor-
related predictors, we could identify a subset of
patients, who might be curatively treated with a fur-
ther therapy (surgical or not), allowing a good local
control.
According to the results of univariate analysis, the
loco-regional recurrence and the distant recurrence (or
cancer-related death) shared some prognostic factors
among the tumor characteristics, such as pT, nodal
status, grading, tumor diameter, ER status, PR status,
and overexpression of Her2 ⁄neu. In contrast, histotype
and an expression of Ki67 were predictors of systemic
progression only, specifically denoting a greater meta-
static capacity.
Similarly, the multivariate models for loco-regional
recurrence free survival and overall survival were dif-
ferent. In fact, for loco-regional recurrence free survival
the Cox regression selected the grading as the only
independent prognostic factor, like a more specific
marker of local aggressiveness. In contrast, for overall
survival the regression model selected grading along
with nodal status and PR status: the nodal status as
a measure of invasive potential and the PR status as a
relevant feature for therapy.
Last result highlights a limitation of our study: in
fact, the sample included patients underwent adjuvant
(and neo-adjuvant) therapy which could favorably
affected prognosis and, hence, our analysis results.
Further limitation of this study regards the duration
of follow-up with the subsequent (not ever reliable)
actuarial survival rates. A substantial proportion of
events occurred after 5 years of follow-up, supporting
the need for longer follow-up (1,6,11).
In conclusion, loco-regional recurrences after breast
cancer surgery are not frequent events. They are mark-
ers of tumor aggressiveness and predictor of an
increased likelihood of cancer-related death. However,
loco-regional recurrence and systemic tumor progres-
sion are partially independent events, since some prog-
nostic factors differ.
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